Our Pricing

Buy Mounjaro Online UK - GPhC Registered Pharmacy

When you buy Mounjaro online UK through Cured Pharmacy, you receive genuine tirzepatide injections from £135.00 dispensed by our GPhC-registered pharmacy following a free clinical assessment by UK prescribers. Every prescription is reviewed by our clinical team led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073), ensuring safe, evidence-based weight management treatment delivered discreetly to your door.

How Mounjaro Tirzepatide Works for Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in the UK [1]. Unlike single-pathway treatments, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously, producing enhanced metabolic effects that regulate appetite, slow gastric emptying, and improve insulin sensitivity.

In the landmark SURMOUNT-1 trial, participants receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks — significantly greater than comparator treatments [1]. The dual-agonist mechanism means patients often report earlier satiety, reduced food cravings, and sustained weight loss when combined with lifestyle modifications. All results vary individually and require ongoing clinical monitoring.

Mounjaro is administered as a once-weekly subcutaneous injection using a pre-filled KwikPen device. Dosing follows a gradual escalation protocol, typically starting at 2.5mg weekly and increasing every four weeks based on tolerability and clinical response, up to a maximum maintenance dose of 15mg weekly [2].

Mounjaro vs Wegovy: Comparing UK Weight Loss Injections

Both Mounjaro and Wegovy are MHRA-licensed injectable medications for chronic weight management, but they differ in mechanism and clinical outcomes. Wegovy contains semaglutide, a GLP-1 receptor agonist, whilst Mounjaro's tirzepatide activates both GIP and GLP-1 pathways. Head-to-head trials suggest tirzepatide produces greater average weight reduction, though individual response varies considerably [1][3].

Wegovy demonstrated an average 14.9% body weight reduction in the STEP 1 trial over 68 weeks, compared to tirzepatide's 22.5% reduction in SURMOUNT-1 [1][3]. Both medications require weekly injections and gradual dose escalation. Your UK prescriber will consider your medical history, previous treatment responses, contraindications, and personal preferences when recommending the most suitable option.

Which Treatment Is Right for You?

Choosing between weight loss treatments depends on multiple clinical factors assessed during your consultation. Patients with type 2 diabetes may benefit from tirzepatide's dual mechanism, whilst those seeking lower starting costs might consider semaglutide-based options. Some individuals tolerate one medication better than another, and previous GLP-1 experience can guide prescriber decisions. Our UK clinical team evaluates your BMI, comorbidities, medication history, and treatment goals to recommend the most appropriate therapy, subject to prescriber approval.

Mounjaro Pricing and Transparent Costs at Cured Pharmacy

At Cured Pharmacy, Mounjaro injections start from £135.00 per prescription, with final pricing determined by your prescribed dose strength following clinical assessment. Unlike many online services, we display upfront pricing before you begin your consultation, ensuring complete transparency without hidden fees or surprise costs at checkout.

Your prescription cost includes the medication, UK prescriber review, dispensing by our GPhC-registered pharmacy team, and discreet delivery to your address. We guarantee the lowest prices in the UK for genuine, MHRA-licensed medicines. Patients requiring ongoing treatment can discuss subscription options with our clinical team to ensure continuity of care and consistent monthly pricing.

What's Included in Your Mounjaro Prescription

Every Mounjaro prescription from Cured Pharmacy includes a comprehensive clinical assessment by a UK-registered prescriber, genuine tirzepatide KwikPen devices manufactured to UK standards, detailed administration instructions, ongoing support from our pharmacy team, and 100% discreet packaging. Follow-up consultations are available to monitor progress, adjust dosing, or address any concerns during your treatment journey.

How to Buy Mounjaro Online UK Through Cured Pharmacy

Purchasing Mounjaro through our GPhC-registered online pharmacy involves a straightforward three-step process designed to meet UK prescribing regulations whilst providing convenient access to treatment. First, complete our free online medical questionnaire, which takes under three minutes and covers your medical history, current medications, weight management goals, and any contraindications.

Next, a UK-registered prescriber reviews your assessment within hours. Our clinical team, overseen by Superintendent Pharmacist Tarun Kumar (GPhC 2233073), evaluates your suitability for tirzepatide based on NICE guidelines and MHRA licensing criteria. If approved, your prescription is issued electronically to our pharmacy. If Mounjaro is not suitable, the prescriber may recommend alternative treatments or advise consultation with your GP.

Finally, our pharmacy team dispenses your medication and arranges discreet delivery to your specified address. We use plain, unmarked packaging to protect your privacy. Most orders are dispatched within 24 hours of prescription approval, with tracked delivery options available. You'll receive clear administration instructions, storage guidance, and access to our pharmacy support line for any questions during treatment.

Mounjaro Dosing Schedule and Administration

Mounjaro follows a structured dose escalation protocol to minimise gastrointestinal side effects whilst optimising weight loss outcomes. Treatment typically begins at 2.5mg injected subcutaneously once weekly for four weeks, then increases to 5mg weekly for another four weeks [2]. Further escalation to 7.5mg, 10mg, 12.5mg, and finally 15mg occurs at four-week intervals, based on individual tolerability and clinical response.

The KwikPen device is designed for self-administration into the abdomen, thigh, or upper arm. Injection sites should be rotated weekly to prevent lipodystrophy. Each pen is single-use and pre-filled with the exact dose, eliminating the need for manual dose measurement. Detailed visual instructions are provided with every prescription, and our pharmacy team can answer administration questions via phone at (+44) 116 4646009.

Consistency is essential — injections should be administered on the same day each week, though the time of day can vary. If you miss a dose and fewer than four days have passed, inject as soon as possible. If more than four days have passed, skip the missed dose and resume your regular schedule. Never double doses to compensate for missed injections [2].

Storage and Handling Requirements

Unopened Mounjaro pens must be refrigerated at 2°C to 8°C and protected from light. Do not freeze the medication, and discard any pens that have been frozen. Once in use, pens may be stored at room temperature (up to 30°C) for up to 21 days. Always check the expiry date before use and dispose of expired medication through a pharmacy take-back scheme or as directed by your local waste disposal authority.

Mounjaro Side Effects and Safety Considerations

The most commonly reported side effects of tirzepatide are gastrointestinal, including nausea, diarrhoea, vomiting, constipation, and abdominal discomfort [1][2]. These effects are typically mild to moderate, occur most frequently during dose escalation, and diminish over time as your body adjusts. Eating smaller, more frequent meals and avoiding high-fat foods can help manage these symptoms.

Serious but rare adverse effects include pancreatitis, gallbladder disease, acute kidney injury, and severe hypoglycaemia when used with insulin or sulfonylureas. Mounjaro carries a boxed warning regarding thyroid C-cell tumours observed in rodent studies, though human relevance remains unclear [2]. It is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

Before starting Mounjaro, inform your prescriber of all medical conditions, particularly pancreatitis history, diabetic retinopathy, kidney disease, or pregnancy plans. Tirzepatide may interact with oral medications by delaying gastric emptying, potentially affecting absorption. Your UK prescriber will review your complete medication list during assessment to identify potential interactions and adjust treatment accordingly.

When to Seek Medical Attention

Contact your GP or NHS 111 immediately if you experience severe abdominal pain that doesn't resolve, persistent vomiting preventing fluid intake, signs of pancreatitis (severe upper abdominal pain radiating to the back), symptoms of gallstones (pain in the upper right abdomen, fever, yellowing of skin), or allergic reactions including rash, itching, or difficulty breathing. Regular monitoring by your prescriber helps identify complications early and ensures safe, effective treatment.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., Stefanski, A., & SURMOUNT-1 Investigators. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC). Retrieved from https://www.medicines.org.uk/emc/product/14881/smpc
3. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., Kushner, R. F., & STEP 1 Study Group. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
4. National Institute for Health and Care Excellence. (2023). Tirzepatide for treating overweight and obesity [ID6380]. NICE technology appraisal guidance. Retrieved from https://www.nice.org.uk/guidance/indevelopment/gid-ta11235

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on multiple factors including adherence to treatment, dietary modifications, and physical activity levels.